Can Wegovy (Semaglutide) Cause Low Libido?

What the Clinical Evidence Actually Says

If you have noticed a drop in sexual desire since starting Wegovy or another semaglutide product, you are not imagining it. But the picture is more nuanced than a simple cause-and-effect relationship.

The FDA label for Wegovy does not include low libido or sexual dysfunction as listed adverse events. Clinical trials for semaglutide focused primarily on weight reduction and cardiovascular outcomes, and sexual desire was not a primary endpoint in those studies. However, a 2023 analysis of the FDA's Adverse Event Reporting System found recurring reports of sexual dysfunction associated with GLP-1 receptor agonists, suggesting the issue deserves closer attention than it has historically received.

Patient forums, pharmacovigilance data, and clinician reports increasingly reflect what the trials may have missed. Absence from a drug label does not mean absence in real-world experience, and understanding the possible mechanisms helps explain why some people notice changes.

How Semaglutide Interacts with Hormones and Brain Chemistry

GLP-1 receptors are expressed in the hypothalamus, the region of the brain that regulates reproductive hormones including luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Semaglutide, as a GLP-1 receptor agonist, may influence this axis in ways that have not been fully studied in the context of sexual health.

Beyond direct receptor activity, semaglutide powerfully suppresses appetite, which leads many people to eat significantly less than before. This rapid caloric restriction can signal a state of physiological stress to the body, prompting it to deprioritize reproductive functions. Both testosterone and estrogen levels can dip as a result, affecting desire in both men and women.

There is also a neurological angle worth considering. GLP-1 agonists appear to modulate dopamine pathways involved in reward-seeking behavior. Sexual desire is partly driven by dopamine signaling, and some researchers theorize that blunting of reward-seeking broadly, which also underlies reduced cravings for food and alcohol reported by many semaglutide users, may extend to reduced sexual motivation as well.

Weight Loss Itself as a Confounding Factor

One of the more counterintuitive aspects of this topic is that significant weight loss generally improves libido over time. Studies consistently show that people who lose substantial weight report better sexual function and higher desire. So why might someone feel less interested in sex while actively losing weight on semaglutide?

The answer likely lies in timing and pace. Rapid early weight loss can temporarily trigger a hormonal stress response, suppressing sex hormones before the body has adjusted to its new state. The first several weeks of treatment, when the caloric deficit is steepest and GI side effects are most pronounced, represent a period of physiological transition that the body treats somewhat like a stressor.

Psychological factors also matter. Body image shifts during weight loss are not always straightforward. Some people feel less confident in their changing bodies before feeling more confident, and that adjustment can influence sexual self-perception and desire.

Causes Worth Comparing: Semaglutide-Related vs. Unrelated

Distinguishing between what semaglutide may be contributing and what was already present or is developing independently is a key part of evaluation.

This comparison is not exhaustive, but it illustrates why a clinical evaluation is more useful than guessing. Several of these causes are addressable without stopping medication.

How the Experience May Differ for Men and Women

The hormonal landscape differs enough between sexes that semaglutide's potential effects on libido may present differently depending on the individual.

For women, semaglutide's appetite suppression and rapid weight change may interact with menstrual cycle regularity and estrogen fluctuation. Women with polycystic ovary syndrome, who commonly use semaglutide, face additional hormonal complexity since PCOS itself affects androgens and cycle regularity. Women using hormonal contraceptives add another variable that can influence how hormonal shifts are perceived and experienced.

For men with obesity-related low testosterone, the long-term trajectory on semaglutide may actually be favorable. As excess weight decreases, testosterone levels in men often rise, since adipose tissue converts testosterone to estrogen. However, this rebound takes time and the early weeks may include a temporary dip before improvement is apparent.

In both sexes, nutritional gaps, particularly inadequate protein and micronutrients like zinc, can suppress sex hormone production. Since semaglutide dramatically reduces appetite, intentional attention to diet quality becomes especially important.

What Patients and Clinicians Can Do

If you are experiencing reduced sexual desire on semaglutide, there are practical and evidence-informed steps worth taking before concluding the medication is the sole culprit.

A baseline hormone panel before starting semaglutide is the most useful preventive measure. It gives both you and your clinician a reference point for testosterone, estradiol, thyroid-stimulating hormone, and prolactin. Without a baseline, it is difficult to know whether a value that looks low today was already low before treatment began.

Dose titration pace and timing can also be adjusted in some cases. Some people tolerate a slower titration that allows the GI system to adapt more gradually, which may reduce the secondary fatigue and nausea that suppress desire in early weeks.

Nutritional support matters too. Ensuring adequate protein intake and monitoring for deficiencies in zinc and other micronutrients can help maintain hormone production even during a caloric deficit.

If low libido persists beyond 8 to 12 weeks, a targeted evaluation of testosterone, estradiol, thyroid function, and prolactin is the appropriate next step. Persistent symptoms at that point are less likely to be a simple adjustment effect and more likely to reflect something that can be specifically identified and treated. Doctronic offers 24/7 consultations with 99.2% treatment plan alignment with board-certified physicians, making it straightforward to get that kind of evaluation without waiting weeks for an in-person appointment.

Frequently Asked Questions

Can Wegovy cause low libido in women?

Wegovy is not officially listed as causing low libido in women, but indirect factors are plausible contributors. Rapid caloric restriction may affect estrogen levels, and semaglutide may interact with menstrual cycle regularity. Women with PCOS or those using hormonal contraceptives may experience additional hormonal complexity during treatment.

Does semaglutide lower testosterone in men?

Semaglutide does not appear to directly lower testosterone, but the rapid caloric deficit it causes may temporarily suppress testosterone production. Over time, weight loss in men with obesity-related low testosterone may actually lead to a rebound in levels. The timeline for this improvement varies from person to person.

How long does low libido last on semaglutide?

For many people, a temporary dip in sexual desire during the first few weeks of semaglutide use corresponds with peak GI side effects and caloric adjustment. If low libido persists beyond 8 to 12 weeks, that warrants a clinical evaluation rather than assuming it will resolve on its own.

Is low sex drive a known side effect of Ozempic?

Low sex drive does not appear on Ozempic's official FDA label as a listed side effect. However, pharmacovigilance databases and patient reports suggest recurring mentions of sexual dysfunction with GLP-1 receptor agonists. This pattern warrants attention and honest conversations with a clinician if it affects you.

Should I stop taking semaglutide if my libido decreases?

Stopping semaglutide is not the recommended first step if libido decreases. Many contributing factors, such as nutritional gaps, fatigue, or underlying hormone issues, can be addressed without discontinuing the medication. A clinician can help identify the specific cause and explore adjustments to dosing, timing, or nutritional support.

The Bottom Line

Low libido on semaglutide is a real concern for some people, but it is often driven by indirect factors rather than a direct drug effect. Rapid caloric restriction, early GI symptoms, nutritional gaps, and hormonal shifts during weight loss can all play a role. In many cases, these contributors are identifiable and manageable without stopping treatment. Men and women may experience this differently, and the picture usually becomes clearer with a targeted hormone evaluation. Doctronic, the first AI legally authorized to practice medicine in the United States, offers free AI consultations and $39 video visits available 24 hours a day, making it easy to get personalized guidance without a long wait. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.